Inventor · disambiguated record
Peter J. Kushner
Also filed as: KUSHNER PETER · KUSHNER PETER J
17 granted patents·12 pending applications·232 citations·filing 1989–2023
94Inventor score
Files withOLEMA PHARMACEUTICALS INC11UNIV CALIFORNIA10GOLDFINE IRA2PFIZER2CALIFORNIA BIOTECHNOLOGY INC1
Top patents by PatentIndex Score
29 records- 0192US10624878B2Tetrahydro-1H-pyrido [3,4-b]indole anti-estrogenic drugsOLEMA PHARMACEUTICALS INC·Filed 2019·Granted Apr 21, 2020·4 cites·24 claims
- 0292US10292971B2Tetrahydro-1H-pyrido[3,4-b]indole anti-estrogenic drugsOLEMA PHARMACEUTICALS INC·Filed 2016·Granted May 21, 2019·6 cites·29 claims
- 0390US11229630B2Tetrahydro-1H-pyrido [3,4-b]indole anti-estrogenic drugsOLEMA PHARMACEUTICALS INC·Filed 2020·Granted Jan 25, 2022·2 cites·19 claims
- 0489US8063249B1Substituted triphenyl butenesKUSHNER PETER·Filed 2009·Granted Nov 22, 2011·24 cites·17 claims
- 0588US9018244B2Benzopyran compounds, compositions and uses thereofOLEMA PHARMACEUTICALS INC·Filed 2012·Granted Apr 28, 2015·20 cites·50 claims
- 0681US5089397ASuperior mammalian expression systemCALIFORNIA BIOTECHNOLOGY INC·Filed 1989·Granted Feb 18, 1992·66 cites·37 claims
- 0781US2024226073A9TETRAHYDRO-1H-PYRIDO[3,4-b]INDOLE ANTI-ESTROGENIC DRUGSOLEMA PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0877US6266622B1Nuclear receptor ligands and ligand binding domainsUNIV CALIFORNIA·Filed 1997·Granted Jul 24, 2001·28 cites·28 claims
- 0976US11672785B2Tetrahydro-1H-pyrido [3,4-b]indole anti-estrogenic drugsOLEMA PHARMACEUTICALS INC·Filed 2021·Granted Jun 13, 2023·0 cites·19 claims
- 1071US8143226B2Tyrosine kinase receptor antagonists and methods of treatment for breast cancerGOLDFINE IRA·Filed 2006·Granted Mar 27, 2012·2 cites·12 claims
- 1170US6236946B1Nuclear receptor ligands and ligand binding domainsFiled 1996·Granted May 22, 2001·32 cites·22 claims
- 1267US6884577B2Methods for screening compounds for estrogenic activityUNIV CALIFORNIA·Filed 2000·Granted Apr 26, 2005·7 cites·20 claims
- 1358US2008085874A1Small molecule potentiator of hormonal therapy for breast cancerUNIV CALIFORNIA·Filed 2007·Application pending·0 cites
- 1455US12370181B2Regimens of estrogen receptor antagonistsOLEMA PHARMACEUTICALS INC·Filed 2020·Granted Jul 29, 2025·0 cites·10 claims
- 1555US2025049768A1Methods of treating estrogen receptor-associated diseasesOLEMA PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1653US5723291AMethods for screening compounds for estrogenic activityUNIV CALIFORNIA·Filed 1995·Granted Mar 3, 1998·19 cites·27 claims
- 1750US2007027215A1Nuclear receptor ligands and ligand binding domainsUNIV CALIFORNIA·Filed 2004·Application pending·0 cites
- 1849US2023129598A1Methods of treating estrogen receptor-associated diseasesOLEMA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1948US6965850B2Methods for modulating nuclear receptor coactivator bindingUNIV CALIFORNIA·Filed 1999·Granted Nov 15, 2005·13 cites·40 claims
- 2047US2017362210A1Anti-estrogenic compoundsPFIZER·Filed 2017·Application pending·0 cites
- 2146US2006149521A1Modulating nuclear receptor coactivator bindingUNIV CALIFORNIA·Filed 2005·Application pending·0 cites
- 2244US2012214758A1Tyrosine kinase receptor antagonists and methods of treatment for pancreatic cancerGOLDFINE IRA·Filed 2012·Application pending·0 cites
- 2343US2016311805A1Anti-estrogenic compoundsPFIZER·Filed 2016·Application pending·0 cites
- 2439US6117638AMethods to screen for transcription factor-coactivator interactionsUNIV CALIFORNIA·Filed 1998·Granted Sep 12, 2000·4 cites·14 claims
- 2539US2023159619A1Compositions and methods for regulating immune system activityOLEMA PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2637US2015197506A1Novel benzopyran compounds, compositions and uses thereofOLEMA PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 2735US6156723ACompositions comprising inhibitors of estrogen responseUNIV CALIFORNIA·Filed 1996·Granted Dec 5, 2000·1 cites·6 claims
- 2827US6586655B2Expression of human estrogen receptors in transgenic miceUNIV CALIFORNIA·Filed 1999·Granted Jul 1, 2003·4 cites·11 claims
- 2925US2002098477A1Methods for screening nuclear transcription factors for the ability to modulate an estrogen responseFiled 1998·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →